Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis)
In previous studies, we demonstrated protection against plague in mice and prairie dogs using a raccoon pox (RCN) virus-vectored vaccine that expressed the F1 capsular antigen of Yersinia pestis. In order to improve vaccine efficacy, we have now constructed additional RCN-plague vaccines containing two different forms of the lcrV (V) gene, including full-length (Vfull) and a truncated form (V307). Mouse challenge studies with Y. pestis strain CO92 showed that vaccination with a combination of RCN-F1 and the truncated V construct (RCN-V307) provided the greatest improvement (P = 0.01) in protection against plague over vaccination with RCN-F1 alone. This effect was mediated primarily by anti-F1 and anti-V antibodies and both contributed independently to increased survival of vaccinated mice.
Citation Information
Publication Year | 2009 |
---|---|
Title | Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis) |
DOI | 10.1016/j.vaccine.2009.10.043 |
Authors | Tonie E. Rocke, Keith P. Iams, S. Dawe, Susan Smith, Judy L. Williamson, Dennis M. Heisey, Jorge E. Osorio |
Publication Type | Article |
Publication Subtype | Journal Article |
Series Title | Vaccine |
Index ID | 70037034 |
Record Source | USGS Publications Warehouse |
USGS Organization | National Wildlife Health Center |